fbpx
PBSELECT-Plus

560 genes 1000x coverage.

Chemotherapy | Targeted Therapy | Immunotherapy

560 Genes at 1000x Coverage

Comprehensive genomic profiling with industry-leading 1000x coverage.  

Block or Blood

The test can be performed on liquid biopsy (blood) or tumor (FFPE).

Patient Profile

Recommended for difficult to treat cancers, aggressive cancers, rare cancers and first line failures.

Multiple Treatment Options

Report will give treatment options including Chemotherapy, Targeted therapy  and Immunotherapy.

Plus-ipad

Plus Points about Plus

The test includes Microsatellite Instability (MSI) and Tumor Mutation Burden (TMB) testing on a 560 gene panel which provides accurate indication for immunotherapy options. 

For the most accurate TMB calculation at least 300 genes must be tested*

Our brochure explains in detail the benefits of the test as well as what is included. 

Detailed and Informative Report

Your report will include:

  • Personalised treatment plan
  • MSI and TBM
  • Clinically actionable mutations
report-PBPlus

Testimonials

  • Helped avoid costly option immunotherapy. Took the chemotherapy from the Plus report.

    Radha Kumar
    3rd Stage Breast Cancer

  • Plus identified 4 options for further treatment. As a late stage patient I thought there was no further options.

    Satyam Joshi
    4th stage lung cancer

Buy PositiveSelect Plus

Comprehensive Testing. Comprehendible Results.

cancer testing in india

Order Test Now

PositiveSelect Plus provides inclusive results by testing 560 genes with industry leading standards. The report will give you treatment options for chemotherapy, targeted therapy and immunotherapy.

Our experts and doctors are happy to guide you. 

Call Now ButtonCall Now